Natco Pharma raises Rs 915 crore via QIP
New Delhi: Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors (QIP), according to a regulatory filing.
During its meeting, the company's committee of directors decided to allocate 1 crore shares at issue price of Rs 915 apiece, Natco Pharma said.
The shares were allotted to eligible qualified institutional buyers pursuant to the QIP amounting to an issue size of Rs 915 crore, it added.
Specific details about utilization of the proceeds were not disclosed.
Shares of the company surged 6.08 percent to close at Rs 1,020.85 apiece on the BSE on Thursday.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd